We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.6%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$8.89B
AUM Growth
+$1.45B
Cap. Flow
+$1.09B
Cap. Flow %
12.29%
Top 10 Hldgs %
26.12%
Holding
266
New
39
Increased
114
Reduced
52
Closed
27

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$63.8M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$50M
3
VR
Validus Hold Ltd
VR
+$44.1M
4
PBYI icon
Puma Biotechnology
PBYI
+$33.5M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
+$30.4M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$59.3M
2
DHR icon
Danaher
DHR
+$44.2M
3
HOLX
Hologic
HOLX
+$42M
4
BDX icon
Becton Dickinson
BDX
+$40.7M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$38.7M

Sector Composition

Rank Sector Weight
1 Financials 21.97%
2 Healthcare 21.33%
3 Technology 19.13%
4 Communication Services 9.13%
5 Industrials 6.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONC
176
BeOne Medicines Ltd
ONC
$33.8B
$7.76M 0.09%
75,000
-25,000
-25% -$1.86M
WDAY icon
177
Workday
WDAY
$33.4B
$7.75M 0.09%
73,508
+43,729
+147% +$4.51M
PPBI
178
DELISTED
Pacific Premier Bancorp
PPBI
$7.71M 0.09%
204,145
+39,555
+24% +$1.42M
SHPG
179
DELISTED
Shire pic
SHPG
$7.66M 0.09%
50,000
+30,000
+150% +$4.7M
USB icon
180
US Bancorp
USB
$99.6B
$7.22M 0.08%
134,744
+6,917
+5% +$362K
PPLI
181
People Inc
PPLI
$3.1B
$7.18M 0.08%
341,421
+41,966
+14% +$815K
BIDU icon
182
Baidu
BIDU
$35.8B
$7.15M 0.08%
28,866
– –
TSLA icon
183
Tesla
TSLA
$1.24T
$6.68M 0.08%
294,000
+211,500
+256% +$4.88M
RPD icon
184
Rapid7
RPD
$634M
$6.45M 0.07%
366,579
+13,264
+4% +$220K
ADSK icon
185
Autodesk
ADSK
$44.3B
$5.77M 0.07%
+51,435
New +$5.67M
VRNS icon
186
Varonis Systems
VRNS
$5.25B
$5.68M 0.06%
407,676
-19,536
-5% -$252K
INCY icon
187
Incyte
INCY
$23.5B
$5.54M 0.06%
47,500
-17,500
-27% -$2.21M
PRLB icon
188
Protolabs
PRLB
$1.86B
$5.26M 0.06%
65,569
-25,600
-28% -$1.85M
CASC
189
DELISTED
Cascadian Therapeutics, Inc.
CASC
$5.11M 0.06%
1,250,000
+250,000
+25% +$956K
RXDX
190
DELISTED
Ignyta, Inc.
RXDX
$4.63M 0.05%
375,000
+275,000
+275% +$2.83M
IPHI
191
DELISTED
INPHI CORPORATION
IPHI
$4.56M 0.05%
114,930
+31,357
+38% +$1.18M
CASH icon
192
Pathward Financial
CASH
$1.81B
$4.34M 0.05%
166,272
-453
-0.3% -$11.7K
ZD icon
193
Ziff Davis
ZD
$1.9B
$4.34M 0.05%
67,567
+10,045
+17% +$680K
AYX
194
DELISTED
Alteryx Inc
AYX
$4.28M 0.05%
+210,000
New +$4.45M
EWBC icon
195
East-West Bancorp
EWBC
$17.9B
$4.25M 0.05%
71,027
+8,527
+14% +$484K
MAIN icon
196
Main Street Capital
MAIN
$4.97B
$3.87M 0.04%
97,414
+8,614
+10% +$338K
CRIS icon
197
Curis
CRIS
$9.53M
$3.86M 0.04%
1,294
+150
+13% +$554K
ARNA
198
DELISTED
Arena Pharmaceuticals Inc
ARNA
$3.83M 0.04%
+150,000
New +$3.44M
DFS
199
DELISTED
Discover Financial Services
DFS
$3.44M 0.04%
53,371
+1,171
+2% +$71K
TWLO icon
200
Twilio
TWLO
$29.1B
$3.3M 0.04%
110,566
-49,320
-31% -$1.48M
6 7
8
9 10

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Polar Capital held 266 positions worth $8.89B, up 20% from $7.43B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Polar Capital deployed $1.09B of net new capital in Q3 2017, opening 39 new positions and adding to 114 existing holdings. Its largest new stake was Puma Biotechnology: 360,000 shares worth $43.1M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Medtronic, an estimated $59.3M trimmed.

  • Polar Capital's largest Q3 2017 buy was Puma Biotechnology: 360,000 shares worth $43.1M.
  • Polar Capital added most to Amgen in Q3 2017, an estimated $63.8M increase.
  • Polar Capital's biggest Q3 2017 reduction was Medtronic, cutting an estimated $59.3M.
  • Polar Capital fully exited Hologic in Q3 2017, selling an estimated $42M.
  • Polar Capital's ten largest holdings make up 26% of its $8.89B portfolio in Q3 2017.
  • Polar Capital opened 39 new positions and closed 27 in Q3 2017.
  • Polar Capital's portfolio value rose 20% quarter-over-quarter to $8.89B.

Based on Polar Capital's 13F filing for Q3 2017, filed 14 Nov 2017.